CD8A and neoplasm: The E7 RNA-LPX vaccine primed high numbers of cytotoxic E749–57-specific CD8+T cells that infiltrated s.c. and mucosal TC-1 and C3 tumors, drove tumor rejection and formed potent memory [13].